文献速递淋巴瘤造血干细胞移植与细胞治疗

T细胞基因治疗原发性免疫缺陷病综述

T cell gene therapy to treat immunodeficiency.
PubMed 文献 · Br J Haematol · 2020-09-10

该综述聚焦于利用自体基因修饰T细胞治疗主要影响淋巴 compartment 的原发性免疫缺陷病,涵盖基因添加与基因编辑策略。文章结合临床经验与临床前研究,讨论了CD40配体缺陷、IPEX综合征、CTLA4缺陷、X连锁淋巴增殖性疾病及家族性HLH等候选疾病。

要点

  • 自体基因修饰T细胞可能治愈主要影响淋巴系统的原发免疫缺陷。
  • T细胞功能恢复对感染免疫、免疫调节和细胞毒性缺陷均有价值。
  • 综述总结了T细胞基因添加/编辑的临床经验与有前景的临床前研究。

核心结论

  • 自体基因修饰T细胞疗法可能为原发免疫缺陷病提供潜在治愈手段。

研究设计与样本

  • 综述总结了T细胞基因添加或基因编辑在不同靶疾病中的临床经验与临床前研究。

主要发现

  • 功能性T细胞不仅参与正常抗感染免疫(CD40配体缺陷中受损),也参与免疫调节(IPEX综合征因FOXP3功能异常、CTLA4缺陷而破坏)和细胞毒性(X连锁淋巴增殖性疾病及家族性HLH综合征中缺陷)。
  • 在所有这些候选疾病中,通过基因治疗恢复T细胞功能可能具有重要价值。

临床怎么用

  • 对于主要影响淋巴 compartment 的原发免疫缺陷病,自体基因修饰T细胞疗法可能成为造血干细胞移植或基因治疗之外的治愈选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The application of therapeutic T cells for a number of conditions has been developed over the past few decades with notable successes including donor lymphocyte infusions, virus-specific T cells and more recently CAR-T cell therapy. Primary immunodeficiencies are monogenetic disorders leading to abnormal development or function of the immune system. Haematopoietic stem cell transplantation and, in specific candidate diseases, haematopoietic stem cell gene therapy has been the only definitive treatment option so far. However, autologous gene-modified T cell therapy may offer a potential cure in conditions primarily affecting the lymphoid compartment. In this review we will highlight several T cell gene addition or gene-editing approaches in different target diseases with a focus on what we have learnt from clinical experience and promising preclinical studies in primary immunodeficiencies. Functional T cells are required not only for normal immune responses to infection (affected in CD40 ligand deficiency), but also for immune regulation [disrupted in IPEX syndrome (immune dysregulation, polyendocrinopathy, enteropathy, X-Linked) due to dysfunctional FOXP3 and CTLA4 deficiency] or cytotoxicity [defective in X-lymphoproliferative disease and familial haemophagocytic lymphohistiocytosis (HLH) syndromes]. In all these candidate diseases, restoration of T cell function by gene therapy could be of great value.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Panchal N, Ghosh S, Booth C, et al. T cell gene therapy to treat immunodeficiency. Br J Haematol. 2020. PMID: 33280098. doi:10.1111/bjh.17070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。